T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Old Republic International
ORI
$10.3B
| $1.04M | ﹤0.01% |
71,147
-5,151
| -7% | -$75.2K |
|
1702
Idacorp
IDA
$8.21B
| $1.04M | ﹤0.01% |
15,710
| – | – |
|
|
LXK
1703
DELISTED
Lexmark Intl Inc
LXK
| $1.04M | ﹤0.01% |
25,100
| – | – |
|
1704
Delek US
DK
$4.12B
| $1.03M | ﹤0.01% |
37,900
| – | – |
|
|
STNR
1705
DELISTED
STEINER LEISURE LTD
STNR
| $1.03M | ﹤0.01% |
22,200
-19,000
| -46% | -$791K |
|
1706
Silgan Holdings
SLGN
$4.3B
| $1.02M | ﹤0.01% |
38,240
| – | – |
|
1707
Carter's
CRI
$1.43B
| $1.02M | ﹤0.01% |
11,700
-1,500
| -11% | -$121K |
|
|
AOL
1708
DELISTED
AOL INC COMMON STOCK
AOL
| $1.02M | ﹤0.01% |
22,040
| – | – |
|
1709
Gaming and Leisure Properties
GLPI
$12.5B
| $1.02M | ﹤0.01% |
34,662
| – | – |
|
|
OA
1710
DELISTED
Orbital ATK, Inc.
OA
| $1.01M | ﹤0.01% |
8,725
-1,300
| -13% | -$151K |
|
1711
TC Energy
TRP
$66.3B
| $996K | ﹤0.01% |
20,200
+1,300
| +7% | +$63K |
|
1712
Popular Inc
BPOP
$11.2B
| $994K | ﹤0.01% |
29,185
| – | – |
|
1713
Jabil
JBL
$38.4B
| $991K | ﹤0.01% |
45,400
-258,713
| -85% | -$5.26M |
|
|
OMED
1714
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $990K | ﹤0.01% |
45,500
-82,253
| -64% | -$1.68M |
|
1715
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $986K | ﹤0.01% |
27,350
+9,200
| +51% | +$344K |
|
|
ALR
1716
DELISTED
Alere Inc
ALR
| $986K | ﹤0.01% |
25,940
-8,800
| -25% | -$340K |
|
|
SFG
1717
DELISTED
STANCORP FINL GRP
SFG
| $985K | ﹤0.01% |
14,100
-4,100
| -23% | -$273K |
|
1718
Mercury Insurance
MCY
$5.84B
| $980K | ﹤0.01% |
17,293
-900
| -5% | -$48.2K |
|
|
GNC
1719
DELISTED
GNC Holdings, Inc.
GNC
| $975K | ﹤0.01% |
20,764
-1,730
| -8% | -$72.6K |
|
|
ENH
1720
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $975K | ﹤0.01% |
16,300
| – | – |
|
|
WCC
1721
WESCO International
WCC
$17.8B
| $972K | ﹤0.01% |
12,751
-1,000
| -7% | -$78.7K |
|
|
SPR
1722
DELISTED
Spirit AeroSystems
SPR
| $964K | ﹤0.01% |
22,400
| – | – |
|
|
HPTX
1723
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $962K | ﹤0.01% |
40,089
-38,263
| -49% | -$863K |
|
1724
Hanover Insurance
THG
$7.74B
| $957K | ﹤0.01% |
13,420
| – | – |
|
1725
Ryman Hospitality Properties
RHP
$7.82B
| $954K | ﹤0.01% |
18,089
-1,500
| -8% | -$74.7K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.